Opioids: Can a Genetic Test Identify an Addict in the Making?
May 31, 2016
(Med Page Today) – When doctors try to figure out whether a patient might become addicted to opioid painkillers, they rely on clinical risk factors like family history, medical history, and other social and environmental clues. Now, two companies — Proove Biosciences and Canterbury Healthcare’s Innovative Medical Testing (IMT) — want to add genetic information to that picture in order to improve risk prediction. But academic geneticists say they may be getting ahead of the science.